This retrospective study enrolled 110 patients with type 2 diabetes and biopsy-proven DN from 2011 to 2018. The pathological findings were confirmed according to the Renal Pathology Society classifications. GBM and TBM thicknesses were determined using the Haas’ direct measurement/arithmetic mean method and orthogonal intercept method, respectively. Cox proportional hazard models were used to investigate the hazard ratios (HRs) for the influence of combined GBM and TBM thickness for predicting end-stage renal disease (ESRD).
Patients were assigned to three groups according to the median GBM and TBM thickness: GBM TBM (GBM <681 nm and TBM <1200 nm), GBM TBM /GBM TBM (GBM ≥681 nm and TBM <1200 nm, or GBM <681 nm and TBM ≥1200 nm), and GBM TBM (GBM ≥681 nm and TBM ≥1200 nm). The GBM TBM /GBM TBM and GBM TBM groups displayed poorer renal function, a more severe glomerular classification and interstitial inflammation, and poorer renal survival rates than the GBM TBM group The GBM TBM /GBM TBM and GBM TBM groups had adjusted HRs of 1.49 (95% confidence interval [CI] 1.21-9.75) and 3.07 (95% CI 2.87-12.78), respectively, compared with the GBM TBM group.
TBM thickness enhanced GBM thickness for renal prognosis in patients with type 2 diabetes.
This article is protected by copyright. All rights reserved.